EMPOWER Breast Grand Rounds – New York, NY
Lenox Hill Hospital/Northwell Health 100 E 77th Street, New York, NY, United StatesThis live activity is focused on the care of patients with early HER2-positive breast cancer.
This live activity is focused on the care of patients with early HER2-positive breast cancer.
This initiative is designed to meet the educational needs of oncologists, oncology pharmacists, oncology nurses and other healthcare professionals and teams involved in the management of patients with cancer who are treated or eligible for treatment with immunotherapy.
This initiative is designed to meet the educational needs of ER physicians and hematologist-oncologists involved in the treatment of patients with hemophilia.
This live activity will cover the treatment and management of patients with chronic lymphocytic leukemia.
This live activity will cover the treatment and management of patients with chronic lymphocytic leukemia.
This initiative is designed to meet the educational needs of hematologists who treat patients with hemophilia A.
This activity will focus on the treatment and management of patients with prostate cancer.
This initiative is designed to meet the educational needs of ER physicians and hematologist-oncologists involved in the treatment of patients with hemophilia.
This live activity is focused on the care of patients with early HER2-positive breast cancer.
This initiative is designed to meet the educational needs of oncologists, oncology pharmacists, oncology nurses and other healthcare professionals and teams involved in the management of patients with cancer who are treated or eligible for treatment with immunotherapy.
This initiative is designed to meet the educational needs of ER physicians and hematologist-oncologists involved in the treatment of patients with hemophilia.
This initiative is designed to meet the educational needs of oncologists, oncology pharmacists, oncology nurses and other healthcare professionals and teams involved in the management of patients with cancer who are treated or eligible for treatment with immunotherapy.